Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1485 entries
Sorted by: Best Match Show Resources per page
Divergence of macrophage phagocytic and antimicrobial programs in leprosy

Louis Stokes Alliances for Minority Participation AND Program Evaluation

Montoya D, Ochoa MT, Teles RMB.
GSID: e-DLXLz4pcIJ
D Montoya, D Cruz, RMB Teles, DJ Lee, MT Ochoa… - Cell host & …, 2009 - Elsevier

Effective innate immunity against many microbial pathogens requires macrophage programs that upregulate phagocytosis and direct antimicrobial pathways, two functions generally assumed to be coordinately regulated. We investigated the regulation of these key functions in human blood-derived macrophages. Interleukin-10 (IL-10)...

Cite
Montoya, D., Cruz, D., Teles, R. M., Lee, D. J., Ochoa, M. T., Krutzik, S. R., ... & Modlin, R. L. (2009). Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell host & microbe, 6(4), 343-353.
Montoya, Dennis, et al. "Divergence of macrophage phagocytic and antimicrobial programs in leprosy." Cell host & microbe 6.4 (2009): 343-353.
Copy Download .nbib Format: MLA
The effects of cyclooxygenase inhibitors on the brain inflammatory response following traumatic brain injury in rats.

Iranian journal of basic medical sciences

Keshavarzi Z, Khaksari M, Razmi Z, Soltani Hekmat A, Naderi V, Rostami S.
PMID: 23492757
Iran J Basic Med Sci. 2012 Sep;15(5):1102-5.

OBJECTIVES: Cytokines such as IL-1β are involved in inflammatory responses. This study evaluated the role of two different kinds of drugs (ibuprofen and celecoxib) on brain IL-10 and IL-1β after traumatic brain injury (TBI) in male rats.MATERIALS AND METHODS:...

Cite
Keshavarzi Z, Khaksari M, Razmi Z, et al. The effects of cyclooxygenase inhibitors on the brain inflammatory response following traumatic brain injury in rats. Iran J Basic Med Sci. 2012;15(5):1102-5
Keshavarzi, Z., Khaksari, M., Razmi, Z., Soltani Hekmat, A., Naderi, V., & Rostami, S. (2012). The effects of cyclooxygenase inhibitors on the brain inflammatory response following traumatic brain injury in rats. Iranian journal of basic medical sciences, 15(5), 1102-5.
Keshavarzi, Zakieh, et al. "The effects of cyclooxygenase inhibitors on the brain inflammatory response following traumatic brain injury in rats." Iranian journal of basic medical sciences vol. 15,5 (2012): 1102-5.
Keshavarzi Z, Khaksari M, Razmi Z, Soltani Hekmat A, Naderi V, Rostami S. The effects of cyclooxygenase inhibitors on the brain inflammatory response following traumatic brain injury in rats. Iran J Basic Med Sci. 2012 Sep;15(5):1102-5. PMID: 23492757; PMCID: PMC3586930.
Copy Download .nbib Format: NLM
Systemic reduction of interleukin-4 or interleukin-10 fails to reduce the frequency or severity of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression.

Ophthalmology and eye diseases

Blalock EL, Chien H, Dix RD.
PMID: 23650460
Ophthalmol Eye Dis. 2012 Sep 25;4:79-90. doi: 10.4137/OED.S10294. Print 2012.

Interleukin-4 (IL-4) and interleukin-10 (IL-10) are key cytokines whose increased production during systemic HIV infection has been associated with decreased cellular immunity during AIDS. We examined whether HIV-induced stimulation of IL-4 or IL-10 production leads to increased susceptibility to...

Cite
Blalock EL, Chien H, Dix RD. Systemic reduction of interleukin-4 or interleukin-10 fails to reduce the frequency or severity of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression. Ophthalmol Eye Dis. 2012;4:79-90doi: 10.4137/OED.S10294.
Blalock, E. L., Chien, H., & Dix, R. D. (2012). Systemic reduction of interleukin-4 or interleukin-10 fails to reduce the frequency or severity of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression. Ophthalmology and eye diseases, 479-90. https://doi.org/10.4137/OED.S10294
Blalock, Emily L, et al. "Systemic reduction of interleukin-4 or interleukin-10 fails to reduce the frequency or severity of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression." Ophthalmology and eye diseases vol. 4 (2012): 79-90. doi: https://doi.org/10.4137/OED.S10294
Blalock EL, Chien H, Dix RD. Systemic reduction of interleukin-4 or interleukin-10 fails to reduce the frequency or severity of experimental cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression. Ophthalmol Eye Dis. 2012 Sep 25;4:79-90. doi: 10.4137/OED.S10294. Print 2012. PMID: 23650460; PMCID: PMC3619657.
Copy Download .nbib Format: NLM
Cutaneous leukocytoclastic vasculitis: the role of lymphocytes and related immune markers.

Postepy dermatologii i alergologii

Gambichler T, Kulik MA, Skrygan M, Rooms I, Höxtermann S.
PMID: 28951703
Postepy Dermatol Alergol. 2017 Aug;34(4):299-305. doi: 10.5114/ada.2017.69307. Epub 2017 Aug 01.

INTRODUCTION: Apart from neutrophils, other immune cells may play a significant pathogenetic role in cutaneous leukocytoclastic vasculitis (CLV).AIM: To investigate lymphocytes and related immunological factors in patients with CLV requiring systemic glucocorticosteroid treatment.MATERIAL AND METHODS: Fourteen patients with severe...

Cite
Gambichler T, Kulik MA, Skrygan M, et al. Cutaneous leukocytoclastic vasculitis: the role of lymphocytes and related immune markers. Postepy Dermatol Alergol. 2017;34(4):299-305doi: 10.5114/ada.2017.69307.
Gambichler, T., Kulik, M. A., Skrygan, M., Rooms, I., & Höxtermann, S. (2017). Cutaneous leukocytoclastic vasculitis: the role of lymphocytes and related immune markers. Postepy dermatologii i alergologii, 34(4), 299-305. https://doi.org/10.5114/ada.2017.69307
Gambichler, Thilo, et al. "Cutaneous leukocytoclastic vasculitis: the role of lymphocytes and related immune markers." Postepy dermatologii i alergologii vol. 34,4 (2017): 299-305. doi: https://doi.org/10.5114/ada.2017.69307
Gambichler T, Kulik MA, Skrygan M, Rooms I, Höxtermann S. Cutaneous leukocytoclastic vasculitis: the role of lymphocytes and related immune markers. Postepy Dermatol Alergol. 2017 Aug;34(4):299-305. doi: 10.5114/ada.2017.69307. Epub 2017 Aug 01. PMID: 28951703; PMCID: PMC5560176.
Copy Download .nbib Format: NLM
Low levels of interleukin-10 in patients with transfusion-related acute lung injury.

Annals of translational medicine

Kapur R, Kim M, Rebetz J, Rondina MT, Porcelijn L, Semple JW.
PMID: 28861436
Ann Transl Med. 2017 Aug;5(16):339. doi: 10.21037/atm.2017.04.37.

No abstract available.

Cite
Kapur R, Kim M, Rebetz J, et al. Low levels of interleukin-10 in patients with transfusion-related acute lung injury. Ann Transl Med. 2017;5(16):339doi: 10.21037/atm.2017.04.37.
Kapur, R., Kim, M., Rebetz, J., Rondina, M. T., Porcelijn, L., & Semple, J. W. (2017). Low levels of interleukin-10 in patients with transfusion-related acute lung injury. Annals of translational medicine, 5(16), 339. https://doi.org/10.21037/atm.2017.04.37
Kapur, Rick, et al. "Low levels of interleukin-10 in patients with transfusion-related acute lung injury." Annals of translational medicine vol. 5,16 (2017): 339. doi: https://doi.org/10.21037/atm.2017.04.37
Kapur R, Kim M, Rebetz J, Rondina MT, Porcelijn L, Semple JW. Low levels of interleukin-10 in patients with transfusion-related acute lung injury. Ann Transl Med. 2017 Aug;5(16):339. doi: 10.21037/atm.2017.04.37. PMID: 28861436; PMCID: PMC5566739.
Copy Download .nbib Format: NLM
Deficient regulatory B cells in human chronic graft-versus-host disease.

Oncoimmunology

de Masson A, Socié G, Bagot M, Bensussan A, Bouaziz JD.
PMID: 26140245
Oncoimmunology. 2015 Apr 01;4(7):e1016707. doi: 10.1080/2162402X.2015.1016707. eCollection 2015 Jul.

Human chronic graft-versus-host disease (cGVHD) is a frequent and disabling complication of allogeneic hematopoietic stem cell transplantation. Regulatory B cells (Bregs) are IL-10-producing B cells that are able to inhibit the innate and adaptive immune responses. We have recently...

Cite
de Masson A, Socié G, Bagot M, et al. Deficient regulatory B cells in human chronic graft-versus-host disease. Oncoimmunology. 2015;4(7):e1016707doi: 10.1080/2162402X.2015.1016707.
de Masson, A., Socié, G., Bagot, M., Bensussan, A., & Bouaziz, J. D. (2015). Deficient regulatory B cells in human chronic graft-versus-host disease. Oncoimmunology, 4(7), e1016707. https://doi.org/10.1080/2162402X.2015.1016707
de Masson, Adèle, et al. "Deficient regulatory B cells in human chronic graft-versus-host disease." Oncoimmunology vol. 4,7 (2015): e1016707. doi: https://doi.org/10.1080/2162402X.2015.1016707
de Masson A, Socié G, Bagot M, Bensussan A, Bouaziz JD. Deficient regulatory B cells in human chronic graft-versus-host disease. Oncoimmunology. 2015 Apr 01;4(7):e1016707. doi: 10.1080/2162402X.2015.1016707. eCollection 2015 Jul. PMID: 26140245; PMCID: PMC4485800.
Copy Download .nbib Format: NLM
Role of high-mobility group box 1 in patients with acute obstructive suppurative cholangitis-induced sepsis.

Journal of inflammation research

Singh A, Feng Y, Mahato N, Li J, Wu C, Gong J.
PMID: 25792849
J Inflamm Res. 2015 Mar 11;8:71-7. doi: 10.2147/JIR.S77539. eCollection 2015.

BACKGROUND: High-mobility group box 1 (HMGB1) is a proinflammatory cytokine that plays an active role during the pathogenesis of inflammatory processes. The primary aim of this study was to detect whether HMGB1 is involved in the pathogenesis of acute...

Cite
Singh A, Feng Y, Mahato N, et al. Role of high-mobility group box 1 in patients with acute obstructive suppurative cholangitis-induced sepsis. J Inflamm Res. 2015;8:71-7doi: 10.2147/JIR.S77539.
Singh, A., Feng, Y., Mahato, N., Li, J., Wu, C., & Gong, J. (2015). Role of high-mobility group box 1 in patients with acute obstructive suppurative cholangitis-induced sepsis. Journal of inflammation research, 871-7. https://doi.org/10.2147/JIR.S77539
Singh, Akanand, et al. "Role of high-mobility group box 1 in patients with acute obstructive suppurative cholangitis-induced sepsis." Journal of inflammation research vol. 8 (2015): 71-7. doi: https://doi.org/10.2147/JIR.S77539
Singh A, Feng Y, Mahato N, Li J, Wu C, Gong J. Role of high-mobility group box 1 in patients with acute obstructive suppurative cholangitis-induced sepsis. J Inflamm Res. 2015 Mar 11;8:71-7. doi: 10.2147/JIR.S77539. eCollection 2015. PMID: 25792849; PMCID: PMC4362899.
Copy Download .nbib Format: NLM
Association between three interleukin-10 gene polymorphisms and coronary artery disease risk: a meta-analysis.

International journal of clinical and experimental medicine

Wang BJ, Liu J, Geng J, Zhang Q, Hu TT, Xu B.
PMID: 26770379
Int J Clin Exp Med. 2015 Oct 15;8(10):17842-55. eCollection 2015.

BACKGROUND: Previous studies have investigated the associations between interleukin-10 (IL-10) gene polymorphisms (-592C/A, -819C/T and -1082G/A) and risk of coronary artery disease (CAD). However, the results were inconsistent. The aim of this study was to clarify the relationship between...

Cite
Wang BJ, Liu J, Geng J, et al. Association between three interleukin-10 gene polymorphisms and coronary artery disease risk: a meta-analysis. Int J Clin Exp Med. 2015;8(10):17842-55
Wang, B. J., Liu, J., Geng, J., Zhang, Q., Hu, T. T., & Xu, B. (2015). Association between three interleukin-10 gene polymorphisms and coronary artery disease risk: a meta-analysis. International journal of clinical and experimental medicine, 8(10), 17842-55.
Wang, Bing-Jian, et al. "Association between three interleukin-10 gene polymorphisms and coronary artery disease risk: a meta-analysis." International journal of clinical and experimental medicine vol. 8,10 (2015): 17842-55.
Wang BJ, Liu J, Geng J, Zhang Q, Hu TT, Xu B. Association between three interleukin-10 gene polymorphisms and coronary artery disease risk: a meta-analysis. Int J Clin Exp Med. 2015 Oct 15;8(10):17842-55. eCollection 2015. PMID: 26770379; PMCID: PMC4694279.
Copy Download .nbib Format: NLM
Ultraviolet-induced alloantigen-specific immunosuppression in transplant immunity.

World journal of transplantation

Hori T, Kuribayashi K, Saito K, Wang L, Torii M, Uemoto S, Iida T, Yagi S, Kato T.
PMID: 25815267
World J Transplant. 2015 Mar 24;5(1):11-8. doi: 10.5500/wjt.v5.i1.11.

After the first observation of the immunosuppressive effects of ultraviolet (UV) irradiation was reported in 1974, therapeutic modification of immune responses by UV irradiation began to be investigated in the context immunization. UV-induced immunosuppression is via the action of...

Cite
Hori T, Kuribayashi K, Saito K, et al. Ultraviolet-induced alloantigen-specific immunosuppression in transplant immunity. World J Transplant. 2015;5(1):11-8doi: 10.5500/wjt.v5.i1.11.
Hori, T., Kuribayashi, K., Saito, K., Wang, L., Torii, M., Uemoto, S., Iida, T., Yagi, S., & Kato, T. (2015). Ultraviolet-induced alloantigen-specific immunosuppression in transplant immunity. World journal of transplantation, 5(1), 11-8. https://doi.org/10.5500/wjt.v5.i1.11
Hori, Tomohide, et al. "Ultraviolet-induced alloantigen-specific immunosuppression in transplant immunity." World journal of transplantation vol. 5,1 (2015): 11-8. doi: https://doi.org/10.5500/wjt.v5.i1.11
Hori T, Kuribayashi K, Saito K, Wang L, Torii M, Uemoto S, Iida T, Yagi S, Kato T. Ultraviolet-induced alloantigen-specific immunosuppression in transplant immunity. World J Transplant. 2015 Mar 24;5(1):11-8. doi: 10.5500/wjt.v5.i1.11. PMID: 25815267; PMCID: PMC4371157.
Copy Download .nbib Format: NLM
Corrigendum to "Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function" [Int. Immunopharmacol. (2015) 423-432].

International immunopharmacology

Sun J, Shen X, Dong J, Zhao J, Zuo L, Wang H, Li Y, Zhu W, Gong J, Li J.
PMID: 27130814
Int Immunopharmacol. 2016 Jun;35:341. doi: 10.1016/j.intimp.2016.03.012. Epub 2016 Apr 05.

No abstract available.

Cite
Sun J, Shen X, Dong J, et al. Corrigendum to "Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function" [Int. Immunopharmacol. (2015) 423-432]. Int Immunopharmacol. 2016;35:341doi: 10.1016/j.intimp.2016.03.012.
Sun, J., Shen, X., Dong, J., Zhao, J., Zuo, L., Wang, H., Li, Y., Zhu, W., Gong, J., & Li, J. (2016). Corrigendum to "Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function" [Int. Immunopharmacol. (2015) 423-432]. International immunopharmacology, 35341. https://doi.org/10.1016/j.intimp.2016.03.012
Sun, Jing, et al. "Corrigendum to "Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function" [Int. Immunopharmacol. (2015) 423-432]." International immunopharmacology vol. 35 (2016): 341. doi: https://doi.org/10.1016/j.intimp.2016.03.012
Sun J, Shen X, Dong J, Zhao J, Zuo L, Wang H, Li Y, Zhu W, Gong J, Li J. Corrigendum to "Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function" [Int. Immunopharmacol. (2015) 423-432]. Int Immunopharmacol. 2016 Jun;35:341. doi: 10.1016/j.intimp.2016.03.012. Epub 2016 Apr 05. PMID: 27130814.
Copy Download .nbib Format: NLM
Little association between the interleukin 10-3575T/A polymorphism and cancer risk: pooled analysis of 15608 cancer cases and 17539 controls.

International journal of clinical and experimental medicine

Zhu B, Xiao C, Zhu B, Zheng Z, Liang J.
PMID: 26550419
Int J Clin Exp Med. 2015 Aug 15;8(8):14335-44. eCollection 2015.

The aim of the present work was to evaluate the association between the interleukin 10 (IL-10) -3575T/A (rs1800890) polymorphism and cancer risk. We performed a met-analysis based on 15 studies, including 15608 cancer cases and 17539 controls. We used...

Cite
Zhu B, Xiao C, Zhu B, et al. Little association between the interleukin 10-3575T/A polymorphism and cancer risk: pooled analysis of 15608 cancer cases and 17539 controls. Int J Clin Exp Med. 2015;8(8):14335-44
Zhu, B., Xiao, C., Zhu, B., Zheng, Z., & Liang, J. (2015). Little association between the interleukin 10-3575T/A polymorphism and cancer risk: pooled analysis of 15608 cancer cases and 17539 controls. International journal of clinical and experimental medicine, 8(8), 14335-44.
Zhu, Biyuan, et al. "Little association between the interleukin 10-3575T/A polymorphism and cancer risk: pooled analysis of 15608 cancer cases and 17539 controls." International journal of clinical and experimental medicine vol. 8,8 (2015): 14335-44.
Zhu B, Xiao C, Zhu B, Zheng Z, Liang J. Little association between the interleukin 10-3575T/A polymorphism and cancer risk: pooled analysis of 15608 cancer cases and 17539 controls. Int J Clin Exp Med. 2015 Aug 15;8(8):14335-44. eCollection 2015. PMID: 26550419; PMCID: PMC4613104.
Copy Download .nbib Format: NLM
Efficacy of Different Durations of Intravenous Methylprednisolone Treatment in Relapses of Multiple Sclerosis.

Noro psikiyatri arsivi

Kulu U, Tiftikcioğlu Bİ, Zorlu Y, Çetiner M, Şener U, Tuna G, Kirkali G.
PMID: 28566960
Noro Psikiyatr Ars. 2017 Mar;54(1):57-61. doi: 10.5152/npa.2016.12382. Epub 2016 Mar 28.

INTRODUCTION: Relapses of multiple sclerosis (MS) are usually treated with high-dose intravenous methylprednisolone (IVMP), given over 3-10 days. There is no consensus on the optimal duration of treatment. In this study, we aimed to investigate whether longer treatment provides...

Cite
Kulu U, Tiftikcioğlu Bİ, Zorlu Y, et al. Efficacy of Different Durations of Intravenous Methylprednisolone Treatment in Relapses of Multiple Sclerosis. Noro Psikiyatr Ars. 2016;54(1):57-61doi: 10.5152/npa.2016.12382.
Kulu, U., Tiftikcioğlu, B. �. �., Zorlu, Y., Çetiner, M., Şener, U., Tuna, G., & Kirkali, G. (2017). Efficacy of Different Durations of Intravenous Methylprednisolone Treatment in Relapses of Multiple Sclerosis. Noro psikiyatri arsivi, 54(1), 57-61. https://doi.org/10.5152/npa.2016.12382
Kulu, Uğur, et al. "Efficacy of Different Durations of Intravenous Methylprednisolone Treatment in Relapses of Multiple Sclerosis." Noro psikiyatri arsivi vol. 54,1 (2017): 57-61. doi: https://doi.org/10.5152/npa.2016.12382
Kulu U, Tiftikcioğlu Bİ, Zorlu Y, Çetiner M, Şener U, Tuna G, Kirkali G. Efficacy of Different Durations of Intravenous Methylprednisolone Treatment in Relapses of Multiple Sclerosis. Noro Psikiyatr Ars. 2017 Mar;54(1):57-61. doi: 10.5152/npa.2016.12382. Epub 2016 Mar 28. PMID: 28566960; PMCID: PMC5439473.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1485 entries